Monday, July 17, 2023 1:30:44 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent MLTX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2025 02:55:59 AM
- MoonLake initiates three new clinical trials and further expands the portfolio of indications for the Nanobody® sonelokimab • GlobeNewswire Inc. • 01/08/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2024 09:30:27 PM
- MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis • GlobeNewswire Inc. • 11/13/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 12:05:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 12:03:28 PM
- MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 11/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/08/2024 08:01:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 11:30:28 AM
- MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11 • GlobeNewswire Inc. • 09/09/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 12:04:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 12:02:10 PM
- MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11 • GlobeNewswire Inc. • 08/07/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:40:47 PM
- MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis • GlobeNewswire Inc. • 06/10/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 09:00:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:59:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:58:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 11:30:17 AM
- MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa • GlobeNewswire Inc. • 05/16/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 12:02:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:01:34 PM
- MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update • GlobeNewswire Inc. • 05/07/2024 12:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/07/2024 11:57:17 AM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM